PATTERNS OF NON-SURGICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN THE UNITED STATES

被引：0
|
作者：
Anger, Jennifer [1 ]
Goldman, Howard [2 ]
Zou, Kelly [3 ]
Luo, Xuemei [3 ]
Russell, David [3 ]
Chapman, Douglass [3 ]
Esinduy, Canan [3 ]
Clemens, J. Quentin [4 ]
机构：
[1] Cedars Sinai Med Ctr, Beverly Hills, CA USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Pfizer Inc, New York, NY USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [41] Critical review of lasers in benign prostatic hyperplasia (BPH)
    Gravas, Stavros
    Bachmann, Alexander
    Reich, Oliver
    Roehrborn, Claus G.
    Gilling, Peter J.
    De La Rosette, Jean
    BJU INTERNATIONAL, 2011, 107 (07) : 1030 - 1043
  • [42] Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
    Kramer, Gero
    Mitteregger, Dieter
    Marberger, Michael
    EUROPEAN UROLOGY, 2007, 51 (05) : 1202 - 1216
  • [43] DEVELOPMENT OF A MODEL FOR CANINE BENIGN PROSTATIC HYPERPLASIA (BPH)
    WADE, DR
    FALVO, RE
    JOURNAL OF ANDROLOGY, 1982, 3 (01): : 35 - 35
  • [44] NATURAL-HISTORY OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    SCHRODER, FH
    BLOM, JHM
    PROSTATE, 1989, : 17 - 22
  • [45] Risk stratification for benign prostatic hyperplasia (BPH) treatment
    Emberton, Mark
    Fitzpatrick, John M.
    Rees, Jon
    BJU INTERNATIONAL, 2011, 107 (06) : 876 - 880
  • [46] DECISIONAL QUALITY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH)
    Shirk, Joseph
    Lambrechts, Sylvia
    Kwan, Lorna
    Munnangi, Meghana
    Sumal, Amit
    Saigal, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04) : E278 - E278
  • [47] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [48] The role of inflammation in the etiopathogenesis of Benign Prostatic Hyperplasia (BPH)
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 15 - 19
  • [49] PATTERNS OF MEDICAL MANAGEMENT OF OVERACTIVE BLADDER (OAB) AND BENIGN PROSTATIC HYPERPLASIA (BPH) IN THE US: WHO, DOES BETTER?
    Anger, Jennifer
    Goldman, Howard
    Luo, Xuemei
    Carlsson, Martin
    Chapman, Douglass
    Zou, Kelly
    Ntanios, Fady
    Russell, David
    Esinduy, Canan
    Clemens, J. Quentin
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S60 - S61
  • [50] INFLUENCE OF AN AROMATASE INHIBITOR ON BENIGN PROSTATIC HYPERPLASIA (BPH)
    SCHULZE, H
    CLAUS, S
    AKTUELLE UROLOGIE, 1994, 25 (03) : 123 - 132
12345